Overview

Full Product Details

Author:   Samir A. Farghaly (, Dept. Obstetrics & Gynecology, Weill Cornell Medical Center)
Publisher:   Oxford University Press Inc
Imprint:   Oxford University Press Inc
Dimensions:   Width: 25.70cm , Height: 2.00cm , Length: 18.30cm
Weight:   0.757kg
ISBN:  

9780190248208

ISBN 10:   0190248203
Pages:   272
Publication Date:   22 November 2018
Audience:   Professional and scholarly ,  Professional & Vocational
Format:   Hardback
Publisher's Status:   Active
Availability:   To order  
Stock availability from the supplier is unknown. We will order it for you and ship this item to you once it is received by us.

Table of Contents

Chapter 1: Antibody Therapeutics for Ovarian Carcinoma and Translation to the Clinic Debra H. Josephs, Heather J. Bax, Giulia Pellizzari, James F. Spicer, Ana Montes, and Sophia N. Karagiannis Chapter 2: Biological Aspects and Clinical Applications of Serum Biomarkers in Ovarian Cancer Rouba Ali- Fehmi and Eman Abdulfatah Chapter 3: Ovarian Cancer Immunity: How Does Immune Suppression Grow Cancer? Vincent Lavoué, Patrick Legembre, Jean Levêque, Fabrice Foucher, Sébastien Henno, and Florian Cabillic Chapter 4: Ovarian Tumor Microenvironment and Innate Immune Recognition Jocelyn Reader, Sarah Lynam, Amy Harper, Gautam Rao, Maya Matheny, and Dana M. Roque Chapter 5: Adoptive Cell Immunotherapy for Epithelial Ovarian Cancer Samir A. Farghaly Chapter 6: Antibody-based Therapy for Ovarian Cancer Yousef Alharbi, Manish S. Patankar, and Rebecca J. Whelan Chapter 7: Epitope/Peptide-based Monoclonal Antibodies for Immunotherapy of Ovarian Cancer Gregory Lee Chapter 8: Dendritic Cell Vaccine Therapy for Ovarian Cancer Caitlin Stashwick, Brian J. Czerniecki, Janos L. Tanyi Chapter 9: Heat Shock Protein Vaccine Therapy for Ovarian Cancer Hiroyuki Abe, Amane Sasada, Shigeki Tabata, and Minako Abe Chapter 10: PD-1 /PDL-1 Inhibitors as Immunotherapy for Ovarian Cancer Scott Moerdler and Xingxing Zang Chapter 11: Growth Factors and Their Corresponding Receptors as Targets for Ovarian Cancer Therapy Anca Maria Cimpean, Andreea Adriana Jitariu, and Marius Raica Chapter 12: Unique Challenges Facing Immunotherapy of Metastatic Ovarian Cancer Michelle N. Messmer, Colleen S. Netherby, and Scott I. Abrams Chapter 13: Clinical Trials of Ovarian Cancer Immunotherapy and Future Directions Justin M. Drerup, Curtis A. Clark, and Tyler J. Curiel

Reviews

Author Information

Samir A. Farghaly, MD, PhD is a Professor Obstetrics and Gynecology at the Joan and Sanford I. Weill Medical College, Graduate School of Medical Sciences; Sandra and Edward Meyer Cancer Center; and New York-Presbyterian Hospital/Weill Cornell Medical Center in New York, NY. He received his MD and PhD in molecular biology from London University. Dr. Farghaly is the Founder and Editor-in Chief of Current Trends in Gynecologic Oncology, and The International Journal of Gynecological, Obstetrical, and Reproductive Medicine Research. He is a member of the editorial boards of 18 international medical journals on Gynecological Cancers, Gene Expression and Therapy, Women's Health, and Gynecology.

Tab Content 6

Author Website:  

Customer Reviews

Recent Reviews

No review item found!

Add your own review!

Countries Available

All regions